Twitxy
Saved
@TargetedOnc's profile picture
View on X

Targeted Onc

@TargetedOnc

Connecting community oncology with emerging science, actionable insights & peer perspectives to advance patient care.
Greater New York Area targetedonc.com Joined July 2012
3.5K Following 21K Followers 47K Posts

Latest posts 5

Targeted Onc @TargetedOnc
🎥 There is no true standard of care for extrapulmonary NEC after platinum.

Amr Mohamed, MD, discusses early phase 1/2 results for zocilurtatug pelitecan and why a randomized phase 3 trial is the next step 👇

@NANETS1 #NANETS2026 #NETCancer

targetedonc.com/view/zocilurta…
www.targetedonc.com Dr Mohamed on Zocilurtatug Pelitecan for Refractory Extrapulmonary NEC | Targeted Onc - Immunothe... Amr Mohamed, MD, reviews zocilurtatug pelitecan phase 1/2 data in platinum-refractory extrapulmonary neuroendocrine carcinoma.
Targeted Onc @TargetedOnc
Separating NET G3 from NEC can be difficult, even for experts.

Halfdan Sorbye, MD, PhD, explains how Rb and p53 staining, KRAS and BRAF testing in pancreatic tumors, and a second opinion can help get the diagnosis right.
#NETs #NETcancer @NANETS1

🎥WATCH
targetedonc.com/view/sorbye-hi…
www.targetedonc.com Dr Sorbye on Separating NET G3 From NEC Before Choosing Therapy | Targeted Onc - Immunotherapy,... Halfdan Sorbye, MD, PhD, discusses why accurately distinguishing NET G3 from NEC is critical, as the wrong first-line therapy can shorten survival.